Security key
09075P105
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 27,093,277
- Total 13F shares
- 3,099,756
- Share change
- -6,339,747
- Total reported value
- $1,890,127
- Put/Call ratio
- 181%
- Price per share
- $0.61
- Number of holders
- 46
- Value change
- -$7,944,274
- Number of buys
- 10
- Number of sells
- 52
Report period
Q3 2024
Institutions
46
Top holders
10
BTAI full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P105
Recent filing periods:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rashmi Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Vipin Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Indu R. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Tarun K. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Suganthi Balasubramanian |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,750
|
$187,110,248 | — | 03 Apr 2023 | |
| Anita Jain |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,300
|
$187,100,398 | — | 03 Apr 2023 | |
| Diwakar Jain |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,300
|
$187,100,398 | — | 03 Apr 2023 | |
| Krishnan Nandabalan |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
8,840,750
mixed-class rows
|
$187,088,358 | — | 06 Apr 2023 | |
| Akrati Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Alka Sood |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Anesha Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Bina Jatin Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| BioXcel Holdings, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| BioXcel LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| Jatin Markand Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Krunal Dilip Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Marshal D. Gibson |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Michael James Aiello |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Pardeep Kumar Sood |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
11%
|
2,987,000
|
$3,823,360 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
8.1%
|
2,205,172
|
$2,822,621 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
970,430
|
$1,242,151 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.6%
|
440,685
|
$564,077 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1%
|
273,135
|
$349,613 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
266,719
|
$341,470 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.75%
|
203,615
|
$260,627 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
194,953
|
$249,540 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.64%
|
173,318
|
$221,847 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.49%
|
133,676
|
$171,105 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.46%
|
125,046
|
$160,059 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.46%
|
124,749
|
$159,679 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.45%
|
122,752
|
$157,123 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
116,563
|
$149,200 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
98,967
|
$126,677 | — | 30 Jun 2024 | |
| Pennant Investors, LP |
13F
|
Company |
0.31%
|
83,900
|
$107,392 | — | 30 Jun 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.28%
|
74,922
|
$95,900 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.27%
|
73,426
|
$93,985 | — | 30 Jun 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.21%
|
57,338
|
$73,000 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.21%
|
55,775
|
$71,392 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
52,483
|
$67,177 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.2%
|
53,010
|
$67,000 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.19%
|
50,251
|
$64,321 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.17%
|
46,503
|
$59,524 | — | 30 Jun 2024 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.16%
|
43,750
|
$56,000 | — | 30 Jun 2024 | |
| Arete Wealth Advisors, LLC |
13F
|
Company |
0.16%
|
43,500
|
$56,000 | — | 30 Jun 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.15%
|
40,599
|
$51,967 | — | 30 Jun 2024 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.15%
|
40,000
|
$51,000 | — | 30 Jun 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.15%
|
39,672
|
$50,780 | — | 30 Jun 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.14%
|
38,050
|
$49,000 | — | 30 Jun 2024 | |
| Centiva Capital, LP |
13F
|
Company |
0.14%
|
37,400
|
$47,872 | — | 30 Jun 2024 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q3 2024
As of 30 Sep 2024,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,099,756 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, STATE STREET CORP, JANE STREET GROUP, LLC, and BNP PARIBAS FINANCIAL MARKETS.
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
71
Q3 2024 holders
46
Holder diff
-25
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.